The main purpose of this legislation is to secure continued funding for Special Diabetes Programs specifically aimed at supporting individuals with Type 1 diabetes. The bill seeks to ensure that these programs can operate effectively over the next several years, providing necessary resources for research, education, and support for those affected by this condition. Key provisions of the legislation include an amendment to an existing law that outlines the funding levels for these diabetes programs. The bill specifies that 60 million will be allocated each year from 2026 through 2030.